Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Free Cash Flow Generation Index
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of CN¥106.53 Million represents 1% of operating cash flow (CN¥133.43 Million). Explore reinvestment intensity of Zhejiang CONBA Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang CONBA Pharmaceutical Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Zhejiang CONBA Pharmaceutical Co Ltd.
Annual Free Cash Flow Generation for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang CONBA Pharmaceutical Co Ltd. Check Zhejiang CONBA Pharmaceutical Co Ltd (600572) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.84x | CN¥795.35 Million | CN¥942.61 Million | CN¥147.26 Million | ▲ +18.3% |
| 2024 | 0.71x | CN¥721.90 Million | CN¥1.01 Billion | CN¥290.63 Million | ▼ -7.1% |
| 2023 | 0.77x | CN¥689.50 Million | CN¥898.64 Million | CN¥209.14 Million | ▲ +2.6% |
| 2022 | 0.75x | CN¥863.73 Million | CN¥1.16 Billion | CN¥291.75 Million | ▲ +106.9% |
| 2021 | 0.36x | CN¥321.56 Million | CN¥889.94 Million | CN¥568.37 Million | ▼ -42.8% |
| 2020 | 0.63x | CN¥789.30 Million | CN¥1.25 Billion | CN¥460.40 Million | ▼ -11.0% |
| 2019 | 0.71x | CN¥656.71 Million | CN¥925.50 Million | CN¥268.79 Million | ▲ +133.1% |
| 2018 | 0.30x | CN¥166.15 Million | CN¥545.78 Million | CN¥379.63 Million | ▼ -48.4% |
| 2017 | 0.59x | CN¥420.47 Million | CN¥712.27 Million | CN¥291.80 Million | ▼ -22.4% |
| 2016 | 0.76x | CN¥737.88 Million | CN¥969.71 Million | CN¥231.83 Million | ▲ +16.2% |
| 2015 | 0.65x | CN¥544.29 Million | CN¥831.26 Million | CN¥286.97 Million | ▲ +114.8% |
| 2014 | 0.30x | CN¥188.20 Million | CN¥617.43 Million | CN¥429.23 Million | ▲ +129.8% |
| 2013 | -1.02x | CN¥-240.97 Million | CN¥235.36 Million | CN¥476.32 Million | ▼ -4293.4% |
| 2012 | 0.02x | CN¥6.00 Million | CN¥245.76 Million | CN¥239.76 Million | ▼ -91.7% |
| 2011 | 0.29x | CN¥55.27 Million | CN¥188.36 Million | CN¥133.09 Million | ▲ +187.4% |
| 2010 | 0.10x | CN¥12.86 Million | CN¥125.93 Million | CN¥113.07 Million | ▼ -84.3% |
| 2009 | 0.65x | CN¥100.07 Million | CN¥153.39 Million | CN¥53.32 Million | ▲ +268.8% |
| 2008 | 0.18x | CN¥17.44 Million | CN¥98.56 Million | CN¥81.12 Million | ▲ +868.2% |
| 2007 | -0.02x | CN¥-1.84 Million | CN¥79.98 Million | CN¥81.83 Million | ▼ -129.7% |
| 2006 | 0.08x | CN¥5.53 Million | CN¥71.20 Million | CN¥65.67 Million | ▲ +748.3% |
| 2005 | 0.01x | CN¥1.08 Million | CN¥117.65 Million | CN¥116.57 Million | ▼ -64.0% |
| 2004 | 0.03x | CN¥1.66 Million | CN¥65.47 Million | CN¥63.81 Million | ▼ -93.6% |
| 2003 | 0.39x | CN¥26.30 Million | CN¥66.64 Million | CN¥40.34 Million | — |